TY - JOUR
T1 - Clinical outcome after infrapopliteal bypass surgery in chronic hemodialysis patients with critical limb ischemia
AU - Kumada, Yoshitaka
AU - Nogaki, Haruhiko
AU - Ishii, Hideki
AU - Aoyama, Toru
AU - Kamoi, Daisuke
AU - Takahashi, Hiroshi
AU - Murohara, Toyoaki
N1 - Publisher Copyright:
© 2015 Society for Vascular Surgery.
PY - 2015/2/1
Y1 - 2015/2/1
N2 - Objective Lower extremity bypass surgery has been widely performed to treat critical limb ischemia (CLI) in patients on hemodialysis (HD). However, the clinical outcome still remains unclear. We investigated the limb salvage rate after infrapopliteal bypass surgery in HD patients with CLI. Methods From April 2006 to January 2013, 226 patients with 236 limbs who electively underwent bypass surgery for treatment of CLI due to infrapopliteal disease were enrolled. Patients were grouped by those who were on HD (n = 177) and those who were not (n = 49). They were monitored for 5 years or until December 2013 if the follow-up period was <5 years. Amputation-free survival, defined as freedom from major amputation or all-cause death, was primarily evaluated. Incidence of reintervention was also analyzed. Results Ulcer/gangrene was present in 206 patients (91.2%), and 233 limbs (98.7%) were treated using autogenous vein. Age was younger (67 ± 9 vs 72 ± 9 years; P =.0011) and ulcer/gangrene was more prevalent (93.8% vs 81.6%, P =.0080) in HD patients than in non-HD patients. During the follow-up period (median, 28 months), 33 (14.6%) major amputations and 28 reinterventions (12.4%) occurred, and 65 patients (28.8%) died. The 5-year amputation-free survival rate was significantly lower in HD patients than in non-HD patients (43.6% vs 78.8%, P =.0033), and the adjusted hazard ratio (HR) for amputation or death for HD patients was 2.36 (95% confidence interval [CI], 1.13-4.92; P =.022). Compared with non-HD patients, the status of HD was similarly an independent risk of major amputation (72.4% vs 92.5%; adjusted HR, 4.36; 95% CI, 1.04-18.3; P =.045) and mortality (56.9% vs 83.2%; adjusted HR, 2.81; 95% CI, 1.30-6.09; P =.0085). However, freedom from reintervention was comparable between the two groups (84.3% vs 86.8%; P =.89). In HD patients, body mass index (HR, 0.86; 95% CI, 0.76-0.96; per 1 kg/m2 increase; P =.014) and C-reactive protein (HR, 1.06; 95% CI, 1.01-1.11; P =.014) independently predicted major amputation. Elevated C-reactive protein levels were also associated with death (HR, 1.04; 95% CI, 1.01-1.09; P =.047). Conclusions The clinical outcome after infrapopliteal bypass surgery was poorer in HD patients with CLI compared with non-HD patients. Malnutrition or chronic inflammation was associated with poor outcome in HD patients with CLI due to infrapopliteal occlusive disease.
AB - Objective Lower extremity bypass surgery has been widely performed to treat critical limb ischemia (CLI) in patients on hemodialysis (HD). However, the clinical outcome still remains unclear. We investigated the limb salvage rate after infrapopliteal bypass surgery in HD patients with CLI. Methods From April 2006 to January 2013, 226 patients with 236 limbs who electively underwent bypass surgery for treatment of CLI due to infrapopliteal disease were enrolled. Patients were grouped by those who were on HD (n = 177) and those who were not (n = 49). They were monitored for 5 years or until December 2013 if the follow-up period was <5 years. Amputation-free survival, defined as freedom from major amputation or all-cause death, was primarily evaluated. Incidence of reintervention was also analyzed. Results Ulcer/gangrene was present in 206 patients (91.2%), and 233 limbs (98.7%) were treated using autogenous vein. Age was younger (67 ± 9 vs 72 ± 9 years; P =.0011) and ulcer/gangrene was more prevalent (93.8% vs 81.6%, P =.0080) in HD patients than in non-HD patients. During the follow-up period (median, 28 months), 33 (14.6%) major amputations and 28 reinterventions (12.4%) occurred, and 65 patients (28.8%) died. The 5-year amputation-free survival rate was significantly lower in HD patients than in non-HD patients (43.6% vs 78.8%, P =.0033), and the adjusted hazard ratio (HR) for amputation or death for HD patients was 2.36 (95% confidence interval [CI], 1.13-4.92; P =.022). Compared with non-HD patients, the status of HD was similarly an independent risk of major amputation (72.4% vs 92.5%; adjusted HR, 4.36; 95% CI, 1.04-18.3; P =.045) and mortality (56.9% vs 83.2%; adjusted HR, 2.81; 95% CI, 1.30-6.09; P =.0085). However, freedom from reintervention was comparable between the two groups (84.3% vs 86.8%; P =.89). In HD patients, body mass index (HR, 0.86; 95% CI, 0.76-0.96; per 1 kg/m2 increase; P =.014) and C-reactive protein (HR, 1.06; 95% CI, 1.01-1.11; P =.014) independently predicted major amputation. Elevated C-reactive protein levels were also associated with death (HR, 1.04; 95% CI, 1.01-1.09; P =.047). Conclusions The clinical outcome after infrapopliteal bypass surgery was poorer in HD patients with CLI compared with non-HD patients. Malnutrition or chronic inflammation was associated with poor outcome in HD patients with CLI due to infrapopliteal occlusive disease.
UR - http://www.scopus.com/inward/record.url?scp=84921512091&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921512091&partnerID=8YFLogxK
U2 - 10.1016/j.jvs.2014.09.007
DO - 10.1016/j.jvs.2014.09.007
M3 - Article
C2 - 25441673
AN - SCOPUS:84921512091
SN - 0741-5214
VL - 61
SP - 400
EP - 404
JO - Journal of Vascular Surgery
JF - Journal of Vascular Surgery
IS - 2
ER -